相关实验视频
Updated: Jul 1, 2025

07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.2K
新型辅助剂在过敏原特异性免疫疗法:我们站在哪里?
Yen-Ju Lin1, Jennifer Zimmermann1, Stefan Schülke1,2
1Section Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.
Frontiers in immunology
|March 11, 2024
概括
在过敏原特异性免疫疗法 (AIT) 中使用辅助剂可增强免疫反应和耐受性. 本综述探讨了已批准和新型辅助剂,以提高AIT治疗I型过敏治疗的疗效和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 治疗开发的治疗方法
背景情况:
- I型过敏 (过敏) 涉及Th2免疫反应对环境抗原.
- 过敏原特异性免疫疗法 (AIT) 是唯一一种针对过敏的疾病修饰治疗方法,旨在重新建立耐受性.
- 传统的AIT面临着长时间治疗,副作用和低过敏原免疫性等挑战.
研究的目的:
- 审查人类AIT中使用的辅助剂,重点关注它们在增强免疫性和免疫反应方面的作用.
- 总结已批准的辅助剂 (氧化,酸,微晶氨酸,MPLA) 和新型候选剂 (乳液,VLP,病毒成分,碳水化合物基,TLR连接体).
- 讨论辅助剂如何通过调节对Th1或调节反应的免疫激活来改善AIT.
主要方法:
- 对过敏原特异性免疫治疗的批准和实验辅助剂的文献综述.
- 辅助性质的分析,包括过敏原释放,免疫细胞激活和抗体产生 (IgG,IgE).
- 在AIT的辅助作用背后的免疫机制的总结.
主要成果:
- 辅助剂增加过敏原的免疫性,并促进所需的免疫反应 (Th1,调节性).
- 已批准的辅助剂包括氧化,酸,微晶氨酸和MPLA.
- 新型辅助剂如乳液,VLP,QS-21,葡萄糖,曼南,鞭毛素和CpG-ODN正在接受调查.
- 辅助剂可以延长过敏原的释放,增加过敏原特异性IgG,减少IgE,并激活免疫细胞.
结论:
- 辅助剂对于提高过敏原特异性免疫疗法的有效性和安全性至关重要.
- 了解辅助机制可以导致针对I型过敏的最佳AIT策略.
- 未来的研究应该专注于阐明辅助剂的免疫学效应,以便更好地临床应用.
相关概念视频
Antigens Involved in Adaptive Immunity
491
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
491
Adrenergic Agonists: Therapeutic Uses
774
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
774
Allergic Reactions
27.4K
Overview
27.4K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Allergic Drug Reactions
842
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
842
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294

